Amundi Asset Management US’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$18.7M Sell
109,345
-16,513
-13% -$2.83M 0.01% 685
2020
Q4
$27.6M Sell
125,858
-168,112
-57% -$36.9M 0.02% 548
2020
Q3
$48.8M Sell
293,970
-70,629
-19% -$11.7M 0.05% 334
2020
Q2
$41.6M Buy
364,599
+54,559
+18% +$6.23M 0.05% 349
2020
Q1
$23.8M Buy
310,040
+75,877
+32% +$5.83M 0.04% 367
2019
Q4
$30.2M Buy
+234,163
New +$30.2M 0.04% 439
2019
Q1
Sell
-268,100
Closed -$11.4K 1660
2018
Q4
$11.4K Buy
268,100
+82,900
+45% +$3.52K 0.01% 620
2018
Q3
$8.72M Buy
+185,200
New +$8.72M 0.01% 771